Ventana Medical Systems Company Profile

02:58 EDT 24th September 2017 | BioPortfolio

Ventana Medical was founded in 1985 by Thomas M. Grogan, M.D., a pathologist at the University of Arizona who was interested in improving the practice of medicine through automation. In 1991, the Company launched its first instrument reagent system and followed with several further product launches before a successful IPO in 1996. The company’s shares are now traded on the NASDAQ under the symbol VMSI. Ventana currently has several IHC instrument systems with a full line of complementary reagents and accessories. Our line of IHC products includes batch-processing and patient-priority systems targeted to hospital clinical and reference labs.


1910 Innovation Park Dr.
United States of America


Phone: (520) 887-2155
Fax: (520) 229-4207

News Articles [2467 Associated News Articles listed on BioPortfolio]

Ventana to create a companion diagnostic for Loxo's larotrectinib

Roche's Ventana Medical Systems Inc. agreed to develop and commercialize a pan-tropomyosin receptor kinase (TRK) immunohistochemistry (IHC) companion diagnostic for Loxo Oncology Inc.'s larotrectinib ...

Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications

TUCSON, Ariz., May 7, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the...

Ventana Medical Systems, Inc. Unveils High-throughput Slide Scanner for Digital Pathology

GRAPEVINE, Texas, Sept. 11, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, unveiled the VENTANA iScan HT slide scanner prototype before a packed audience at...

Cancer Genetics Partners With Ventana Medical Systems, A Member Of The Roche Group To Ensure Market Access To Predictive Biomarker Test For New mmuno-Oncology (IO) Therapy For Advanced Bladder Cancer

  Life Sciences Jobs   ...

New director named to Merit Medical Systems' board

Thomas Gunderson, who worked at Pfizer's American Medical Systems for 12 years, has been tapped to serve on Merit Medical Sys -More- 

FDA Approves Roche’s Companion Diagnostic to Identify ALK-Positive NSCLC Patients

Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced US Food and Drug Administration (FDA) approval of the VENTANA ALK (D5F3) CDx Assay as a companion diagnostic to identify ALK-positive non-small cell l...

3D Systems Announces New Certified Partner Program to Accelerate its Industry-Leading Precision ...

rms Company named first certified medical device manufacturing partnerrms Company to receive preferred access to experts from 3D Systems and plans to exclusively use 3D Systems’ platforms for ma...

Funding round pulls in $20M for Visunex Medical Systems

A round of Series B financing has brought in $20 million for Fremont, Calif.-based Visunex Medical Systems, a maker of integr -More- 

PubMed Articles [4522 Associated PubMed Articles listed on BioPortfolio]

Ethnicity Recording in Primary Care Computerised Medical Record Systems: An Ontological Approach.

Ethnicity recording within primary care computerised medical record (CMR) systems is suboptimal, exacerbated by tangled taxonomies within current coding systems.Objective To develop a method for exten...

Collaborative Systems Biology Projects for the Military Medical Community.

This pilot study was conducted to examine, for the first time, the ongoing systems biology research and development projects within the laboratories and centers of the U.S. Army Medical Research and M...

Ventana immunohistochemistry assay for anaplastic lymphoma kinase gene rearrangement detection in patients with non-small cell lung cancer: A meta-analysis.

The aim of this study was to evaluate the diagnostic value of Ventana immunohistochemistry (IHC) assay for anaplastic lymphoma kinase (ALK) gene rearrangement screening in patients with non-small cell...

Understanding public perception of the need for major change in Latin American healthcare systems.

The opinions and experiences of the public regarding health services are valuable insights into identifying opportunities to improve healthcare systems. We analyzed the 2012-2013 Public Opinion Health...

Engaging Learners in Health System Quality Improvement Efforts.

In 1999, an Institute of Medicine report spurred health care organizations to implement systems-based quality improvement efforts and tackle patient safety. Simultaneously, the Accreditation Council f...

Clinical Trials [2217 Associated Clinical Trials listed on BioPortfolio]

Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)

VENTANA is a "window-of-opportunity" trial that will explore whether, similar to CDK4/6 inhibitors, Oral Metronomic Vinorelbine in combination with Letrozole induces a superior anti-prolif...

Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients With St. Jude Medical Implantable Cardioverter Defibrillator (ICD) Systems or Cardiac Resynchronization Therapy Defibrillation (CRT-D) Systems.

The intent of this observational study is to understand the role of non-invasive programmed stimulation (NIPS) to induce substrate based MMVT in patients receiving new St. Jude Medical ICD...

Biventricular Pacing in the Pediatric Population

Hypothesis 1 (H1): Epicardial biventricular pacing is a safe and feasible method of pacing in young patients. Over the last two years, physicians at Children’s Healthcare of Atlanta hav...

Prospective Evaluation Comparing the Effects of Constant Current Versus Constant Voltage in Deep Brain Stimulation Using Hybrid Systems

This post-marketing evaluation has been designed to consistently investigate the subject's preference when switching from a Medtronic® constant voltage or constant current device to a St ...

SpO2 Accuracy Validation of Pulse Oximetry Systems During Motion and Non-Motion Conditions

Study to evaluate the %SpO2 accuracy performance of the Nonin Medical pulse oximetry systems.

Companies [2894 Associated Companies listed on BioPortfolio]

Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc. ("VMSI") develops, manufactures, and markets instrument/reagent systems that automate tissue preparation and slide staining in clinical histology and drug discovery labor...

Ventana Medical Systems

Ventana Medical was founded in 1985 by Thomas M. Grogan, M.D., a pathologist at the University of Arizona who was interested in improving the practice of medicine through automation. In 1991, the Comp...

La Ventana Treatment Programs

La Ventana Treatment Programs focus on understanding the complexity and progressive nature of eating disorders and substance abuse. Individuals seeking recovery may struggle with ...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Ventana Clinical Research Corporation

Ventana was founded in 1997 by Dr. Edward Sellers, Dr. Myroslava Romach, Dr. Neil Shear and Gail Somer after having established international reputations with more than thirty years of quality, innova...

More Information about "Ventana Medical Systems" on BioPortfolio

We have published hundreds of Ventana Medical Systems news stories on BioPortfolio along with dozens of Ventana Medical Systems Clinical Trials and PubMed Articles about Ventana Medical Systems for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ventana Medical Systems Companies in our database. You can also find out about relevant Ventana Medical Systems Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record